[Statins--new mechanisms of action and new indications].
Savolainen
M
M
Oulun yliopisto, sisätautien klinikka Kajaanintie 50 90220 Oulu. markku.savolainen@oulu.fi
D000367:Age Factors; D002784:Cholesterol / Q000378:metabolism; D003324:Coronary Artery Disease / Q000188:drug therapy*; D003925:Diabetic Angiopathies / Q000517:prevention & control*; D004347:Drug Interactions; D016232:Endothelins / Q000187:drug effects; D006084:Graft Rejection / Q000517:prevention & control; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use*; D006938:Hyperlipoproteinemia Type II / Q000188:drug therapy*; D010024:Osteoporosis / Q000517:prevention & control; D012307:Risk Factors; D020521:Stroke / Q000517:prevention & control*
D016232:Endothelins; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D002784:Cholesterol